AIG
45
-12
WM
80
6
AES
46
2
STI
49
2
FOX
26
-2
VIX
38
-3
GS
62
3
HSIC
51
3
MO
45
-2
O
48
-14
EXR
44
4
PNW
69
2
AMT
39
3
MHK
27
-3
TRV
42
5
MKC
38
2
ICE
63
6
CAT
55
-2
KMB
42
-2
EL
25
-2
AIG
45
-12
WM
80
6
AES
46
2
STI
49
2
FOX
26
-2
VIX
38
-3
GS
62
3
HSIC
51
3
MO
45
-2
O
48
-14
EXR
44
4
PNW
69
2
AMT
39
3
MHK
27
-3
TRV
42
5
MKC
38
2
ICE
63
6
CAT
55
-2
KMB
42
-2
EL
25
-2
Financhill
Back

Pathward Financial, Inc. Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Buy
60

CASH
Pathward Financial, Inc.

Last Price:
$89.98
Seasonality Move:
9.74%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Buy
60
Pathward Financial, Inc. (CASH) is a Buy

Is Pathward Financial, Inc. a Buy, Sell or Hold?

  • The current Pathward Financial, Inc. [CASH] share price is $90.00. The Score for CASH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • CASH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CASH Stock Price Chart

What is Pathward Financial, Inc.'s stock price today?

  • The Pathward Financial, Inc. share price today is $90.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CASH is experiencing buying pressure, which is a positive indicator for future bullish movement.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CASH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 51.07 Buy
Chaikin Money Flow: 178497 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.02 - 91.2) Sell
Bollinger Bands (100): (72.13 - 90.87) Buy

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

CASH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.17 Buy
20-day SMA: 89.81 Buy
50-day SMA: 90.47 Sell
200-day SMA: 78.76 Buy
8-day EMA: 89.48 Buy
20-day EMA: 89.83 Buy
50-day EMA: 88.1 Buy
200-day EMA: 80.38 Buy

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Pathward Financial, Inc. Earnings Growth & CASH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $1.99 per share, an increase this year of $1.17 per share, and an increase next year of $0.97 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Pathward Financial, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):